A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

NCT03061201 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer